Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SPECTA: Screening Cancer Patients for Efficient Clinical Trial Access

NCT02834884 is registered in ClinicalTrials.gov with European Organisation for Research and Treatment of Cancer - EORTC as lead sponsor.

NCT NCT02834884
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02834884 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SPECTA: Screening Cancer Patients for Efficient Clinical Trial Access
Lead sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Phase
Observational
Overall status
Recruiting
Start date
May 3, 2017
Completion date
October 31, 2031
Enrollment
4,975 (estimated)
Sites
136

Conditions

As the registry lists them; a condition with its own page is linked.

all tumor types